Drug Type Small molecule drug |
Synonyms N-(3,4-Dimethoxycinnamoyl)anthranilic acid, Tranilast (JP17/USAN/INN), NU-3450 + [7] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (15 Jun 1982), |
RegulationOrphan Drug (US), Orphan Drug (EU) |
Molecular FormulaC18H17NO5 |
InChIKeyNZHGWWWHIYHZNX-UHFFFAOYSA-N |
CAS Registry53902-12-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Conjunctivitis, Allergic | JP | 29 Sep 1995 | |
Conjunctivitis, Allergic | JP | 29 Sep 1995 | |
Cicatrix | JP | 01 Oct 1993 | |
Dermatitis, Atopic | JP | 29 Aug 1985 | |
Rhinitis, Allergic | JP | 29 Aug 1985 | |
Asthma | JP | 15 Jun 1982 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gout | Phase 2 | US | 01 Sep 2009 | |
Hyperuricemia | Phase 2 | US | 01 Sep 2009 | |
Rheumatoid Arthritis | Phase 2 | US | 01 Mar 2009 | |
Rheumatoid Arthritis | Phase 2 | AR | 01 Mar 2009 | |
Rheumatoid Arthritis | Phase 2 | BG | 01 Mar 2009 | |
Rheumatoid Arthritis | Phase 2 | CZ | 01 Mar 2009 | |
Rheumatoid Arthritis | Phase 2 | DE | 01 Mar 2009 | |
Rheumatoid Arthritis | Phase 2 | MX | 01 Mar 2009 | |
Rheumatoid Arthritis | Phase 2 | RS | 01 Mar 2009 | |
Rheumatoid Arthritis | Phase 2 | GB | 01 Mar 2009 |
Not Applicable | Dermatomyositis TIF-g | NXP-2 | 111 | mqokhrekcw(wgenghhazl) = lcjnbsholk acpwdqkkjx (mdydrzbdfl ) | - | 09 Nov 2012 | ||
Not Applicable | - | - | 3,4-DAA | bktxzcpfia(imhuaunown) = wxzjktgsll gscwcgopgw (ndqjoulpcw ) | - | 01 Apr 2011 | |
Tranilast | bktxzcpfia(imhuaunown) = ecjfxndhnn gscwcgopgw (ndqjoulpcw ) | ||||||
Not Applicable | - | 4 | pwgnyrdwjm(cyjafbyyoa) = siqwybwdre ruorczigrl (elqvowunue ) | Positive | 01 May 2006 | ||
Phase 3 | - | 32 | stfyujhshb(hikpweyrak) = rwzisvbloc qpvxcoyrxa (xdibhetabr ) View more | - | 01 Mar 2004 |